SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Update on pilot programme

3 May 2016 07:00

RNS Number : 9008W
Sabien Technology Group PLC
03 May 2016
 

3rd May 2016

 

Sabien Technology Group Plc

 

("Sabien" or "the Group")

 

Update on pilot programme

 

The Board of Sabien Technology Group plc (AIM: SNT), the manufacturer and supplier of M1G and M2G, energy efficiency technologies, is pleased to provide an update on the progress of its new piloting strategy.

 

In the last Annual Report, we stated that the Group had set a new five year strategy to improve sales substantially. To achieve this the key objective for management was to significantly scale up large multi-site M2G pilots in each year over the next five years both in the UK and overseas by offering "free" pilots to potential clients. The target for the 2015-16 heating season was to run up to 35 pilots compared to 8 in 2014-15. We are pleased to report that we expect at least 34 pilots will be completed (32 in the UK and two overseas) and that the initial signs are that the anticipated positive impact on the sales pipeline is being achieved.

 

UK pilot programme

 

At the time of the interim results announcement in February 2016, we stated that the Group had agreements for pilots with 30 clients of which 18 were awaiting survey and 12 were in measurement. As of today, 35 clients have signed up for pilots in the 2015-6 heating season. Of these 10 have been completed with reports submitted to clients, 21 are in measurement, 2 are awaiting installation and 2 are being surveyed. The 10 reports all demonstrate the expected savings for the clients. The Board believes that 32 UK pilots will be completed this financial year with a further 3 completed after the Group's year end.

 

Overseas pilot programme

 

In addition to the UK pilot programme, as a result of demand from our US distributor, we assisted it with 5 pilots for large school districts. 2 of these have been completed and reports have been submitted and the other 3 pilots are scheduled to start before the financial year end. As with the UK pilots the reports to date demonstrate the expected savings for the end users.

 

Sales pipeline

 

The estimated pipeline value of the 10 completed pilots is £3.5m (on average above the minimum £250k necessary to qualify for a pilot) and one of these clients has already placed an initial order for £110k. The Group has reviewed its historic pipeline and the updated pipeline now includes only those prospects where it is in active discussion with the client on implementation. The sales pipeline at end April 2016 stood at £7.4m.

 

Trading update scheduled for early June

 

The Group expects to update the market on trading for FY2016 at the beginning of June. With the results of the 2015-16 pilot programme and the interest already shown in the Group's pilot programme for the 2016-2017 heating season, the Directors are confident that the strategy to return the company to profitability in the 2017-18 financial year is achievable.

For further information:

Sabien Technology Group plc

Alan O'Brien, CEO Tel: +44 (0) 207 993 3700

Gus Orchard, CFO www.sabien-tech.co.uk

 

Stockdale Securities Ltd

Antonio Bossi Tel +44 (0) 207 601 6100

Rose Ramsden www.stockdalesecurities.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDAKCDQPBKDKQB
Date   Source Headline
1st Oct 20127:00 amRNSPreliminary Statement of Final Results
30th Aug 20122:30 pmRNSRetirement of Chairman
10th Jul 20127:00 amRNSPost Close Trading Statement
7th Mar 20127:00 amRNSRe Contract
7th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
12th Jan 201212:20 pmRNSDirector Declaration
12th Jan 20129:27 amRNSCapital Reorganisation
9th Jan 20127:00 amRNSNotice of Results
5th Jan 20127:00 amRNSChange of Adviser
19th Dec 201110:54 amRNSDirector Declaration
29th Nov 201110:19 amRNSHolding(s) in Company
24th Nov 20117:00 amRNSResult of AGM
21st Nov 201110:26 amRNSHolding(s) in Company
17th Nov 201111:23 amRNSHolding(s) in Company
4th Nov 20111:50 pmRNSHolding(s) in Company
1st Nov 20117:00 amRNSAnnual Report and Accounts
7th Oct 20117:00 amRNSNew Contract Win
3rd Oct 20117:00 amRNSFinal Results
12th Sep 20117:00 amRNSNew Contract Win
25th Aug 20117:00 amRNSNew Contract Win
11th Jul 20117:00 amRNSPost Year End Trading Update
29th Jun 20111:12 pmRNSM2G sale to US Distributor
2nd Jun 201112:15 pmRNSNotice of Results
8th Apr 201111:28 amRNSM2G sale to US Distributor
2nd Mar 201111:44 amRNSHolding(s) in Company
1st Mar 201111:08 amRNSHolding(s) in Company
7th Feb 20117:00 amRNSHalf Yearly Report
5th Jan 20117:00 amRNSNotice of Results and Trading Update
26th Nov 20107:00 amRNSDirector/PDMR Shareholding
25th Nov 20107:00 amRNSResult of AGM
17th Nov 20107:00 amRNSAward of Contract
12th Nov 20104:12 pmRNSAnnual Financial Report
29th Oct 20107:00 amRNSPreliminary Results
18th Oct 20107:00 amRNSNotice of Results
15th Oct 20107:00 amRNSDirectorate Change
20th Sep 20107:00 amRNSAward of Contract
6th Aug 20107:00 amRNSAward of Contract
5th Jul 20107:00 amRNSAward of Contract
24th Jun 20107:00 amRNSAward of Contract
1st Jun 20107:00 amRNSTrading Statement
17th May 20107:00 amRNSChange of Adviser
1st Apr 201012:37 pmRNSGrant of options
25th Feb 20107:00 amRNSHalf Yearly Report
2nd Dec 20097:00 amRNSNew Contract Win
9th Nov 20097:00 amRNSAdjustment to number of warrants in issue
28th Oct 20097:00 amRNSPreliminary Results - 12 months ended 30 June 2009
14th Oct 20097:00 amRNSPlacing
7th Oct 20097:00 amRNSContract award
28th Sep 200911:40 amRNSAlliance Agreement with Jones Lang LaSalle

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.